Concepedia

Author

M V van Krugten

Leiden University Medical Center

Also Known As

M V van Krugten, M. V. Van Krugten, M. V. van Krugten, M. van Krugten, M.V. Krugten, M.V. van Krugten, MV van Krugten, Michiel V van Krugten, Michiel V. Van Krugten, Michiel V. van Krugten

22

Publications

2.7K

Citations

14

H-Index

14

Concepts

All Affiliations

Leiden University Medical CenterAmsterdam UMC Location Vrije Universiteit AmsterdamAdmiraal De Ruyter ZiekenhuisFranciscus VlietlandSint Franciscus Gasthuis
MV

About

M V van Krugten is an author at Leiden University Medical Center specializing in immunology, rheumatology, and autoimmune disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

226

2

Immunology

3

3

226

3

Rheumatology

3

3

226

4

Autoimmune Disease

3

3

226

5

Pathology

2

2

149

M V van Krugten

×

16

Publications

2.6K

Citations

14

H-Index

YearCitations

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart,

Arthritis & Rheumatism

2005

1.4K

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart,

Arthritis & Rheumatism

2008

196

TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus

M. J. Rood, M V van Krugten, Eric Zanelli,

Arthritis & Rheumatism

2000

192

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

P.H. de Jong, J. M. W. Hazes, Huub KH Han,

Annals of the Rheumatic Diseases

2014

125

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

A. E. van der Bijl, Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra,

Arthritis & Rheumatism

2007

122

Functional Analysis of a Human Tumor Necrosis Factor α (TNF-α) Promoter Polymorphism Related to Joint Damage in Rheumatoid Arthritis

Eric L. Kaijzel, M V van Krugten, Brigitta M. N. Brinkman,

Molecular Medicine

1998

105

Tumor necrosis factor‐α gene polymorphisms in relation to periodontitis

Jeroen Craandijk, M V van Krugten, Cor L. Verweij,

Journal Of Clinical Periodontology

2002

84

Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis

Melek Güler-Yüksel, Cornelia F Allaart, I. Watt,

Osteoarthritis and Cartilage

2010

77

Tumor Necrosis Factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease

Mehmet Küçükaycan, M V van Krugten, Herman-Jan Pennings,

Respiratory Research

2002

69

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

Naomi B. Klarenbeek, S M van der Kooij, T. Huizinga,

Annals of the Rheumatic Diseases

2010

69

Page 1